Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDPK1 | O15530 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | ABL1 | P00519 | 1/20 | 0.31 |
| ▸ | RAD52 | P43351 | 1/20 | 0.31 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.31 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31380770 | 0.79 | XDH (0.37) | PDPK1CYP1A2CYP2C19ABL1RAD52 | |
| Methylguanine SCHEMBL1336757 | 0.79 | CDK1 (0.41) | PDPK1 | |
| SCHEMBL22700363 | 0.79 | MEN1 (0.37) | PDPK1CYP1A2CYP2C19ABL1RAD52 | |
| SCHEMBL9503831 | 0.79 | PDPK1 (0.36) | PDPK1CYP1A2CYP2C19ABL1RAD52 | |
| SCHEMBL1443986 | 0.79 | XDH (0.37) | PDPK1CYP1A2CYP2C19ABL1RAD52 | |
| SCHEMBL4525138 | 0.78 | HPGD (0.35) | PDPK1CYP1A2CYP2C19 | |
| SCHEMBL18961720 | 0.76 | GAA (0.35) | PDPK1CYP1A2CYP2C19 | |
| SCHEMBL9925954 | 0.76 | PDPK1 (0.34) | PDPK1DYRK1A | |
| SCHEMBL2526551 | 0.75 | PARP1 (0.32) | PDPK1DYRK1A | |
| SCHEMBL8959020 | 0.73 | MGMT (0.46) | CYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3512860-B1 | NUCLEOSIDE AND NUCLEOTIDE ANALOGUES BEARING A QUATERNARY ALL-CARBON STEREOGENIC CENTER AT THE 2' POSITION AND METHODS OF USE AS A CARDIOPROTECTIVE AGENT | LCB PHARMA INC (CA) | 2020-11-25 | — | — | EP | disclosed |
| WO-2018049534-A1 | NUCLEOSIDE AND NUCLEOTIDE ANALOGUES BEARING A QUATERNARY ALL-CARBON STEREOGENIC CENTER AT THE 2' POSITION AND METHODS OF USE AS A CARDIOPROTECTIVE AGENT | LCB PHARMA INC. (CA) | 2018-03-22 | — | — | WO | disclosed |